Advisory Committees
-
Presentations for the March 14, 2013 Meeting of the Pediatric Advisory Committee to the FDA
Persons with disabilities having problems accessing any of the PDF files below may call (301) 796-3634 for assistance.
-
Presentations
Menactra Meningococcal (PDF - 112KB)Modification of CBER Presentations to the Pediatric Advisory Committee (PDF - 52KB)Hizentra Globulin Subcutaneous (PDF - 37KB)Almita (PDF - 98KB)Gadavist (PDF - 77KB)Kedbumin Albumin and Natroba (PDF - 55KB)Designated Abbreviated Review Process (PDF - 77KB)Pediatric Focused Safety Review: Moxeza (moxifloxacin hydrochloride ophthalmic solution) 0.5% (PDF - 69KB)Approach to Pediatric Bacterial Conjunctivitis (PDF - 103KB)Kytril Injection (PDF - 173KB)- Nexium and Nexium IV (PDF - 116KB)
INOmax (PDF - 216KB)Systemic JIA Treatment and Complications (PDF - 1.1MB)Actemra (PDF - 144KB)Lamictal XR (PDF - 93KB)Pediatric Focused Safety Review: Invega Extended-Release Tablets (paliperidone) (PDF - 200KB)Pharmacogenetics of Codeine (PDF - 388KB)Death and respiratory arrest related to ultra- rapid metabolism of codeine to morphine (PDF - 183KB)
-
-
-
